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Abstract: Graphene oxide nanoparticles (GONPs) have attracted a lot of attention due to their many
applications. These applications include batteries, super capacitors, drug delivery and biosensing.
However, few studies have investigated the effects of these nanoparticles on the immune system.
In this study, the in vitro effects of GONPs on the immune system was evaluated by exposing
murine macrophages, RAW 264.7 cells and human whole blood cell cultures (to GONPs. The effects
of GONPs on RAW cells were monitored under basal conditions. The whole blood cell cultures
were exposed to GONPs in the presence or absence of the mitogens lipopolysaccharide (LPS) and
phytohaemmagglutinin (PHA). A number of parameters were monitored for both RAW and whole
blood cell cultures, these included cytotoxicity, inflammatory biomarkers, cytokines of the acquired
immune system and a proteome profile analysis. The GONPs were cytotoxic to both RAW and whole
blood cell cultures at 500 µg/mL. In the absence of LPS, GONPs elicited an inflammatory response
from the murine macrophage, RAW and whole blood cell cultures at 15.6 and 5 µg/mL respectively.
This activation was further corroborated by proteome profile analysis of both experimental cultures.
GONPs inhibited LPS induced interleukin 6 (IL-6) synthesis and PHA induced interferon gamma
(IFNγ) synthesis by whole blood cell cultures in a dose dependent manner. In the absence of mitogens,
GONPs stimulated IL-10 synthesis by whole blood cell cultures. The current study shows that GONPs
modulate immune system biomarkers and that these may pose a health risk to individuals exposed
to this type of nanoparticle.
Keywords: graphene oxide nanoparticles; cytotoxicity; macrophage activation; humoral immune response
1. Introduction
Graphene (G) is a two-dimensional (2-D) carbon material, with a hexagonal structure (honeycomb
lattice) consisting of sp2 hybridized atoms, which has been isolated from its three-dimensional parent
material, graphite [1–3]. Graphene oxide (GO) is a single carbon layer graphene derivative, containing
oxygen-bearing functional groups such as carboxyl and hydroxyl groups [2,4,5]. These groups are
acquired when graphene undergoes oxidization [2]. These oxidized graphene nanoparticles possess
unique characteristics such as electronic and thermal conductivity, superior mechanical strength
and optical properties [6]. Due to these exceptional physiochemical properties of graphene oxide
nanoparticles (GONPs), it has a broad range of applications in a number of fields. These fields include
electrochemistry, biomedicine, biosensing, drug delivery, high energy capacity batteries and super
capacitors to name a few. However, these properties do not necessarily ensure that GONPs are good
drug delivery carriers [2,5].
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Due to the applications of GONPs it is inevitable that these nanoparticles will be released into
the environment and may directly or indirectly affect human health. Therefore, it is imperative that
the effects of GO be investigated. As nanoparticles, due to their properties may be easily transported,
which alters bioavailability and affects cellular toxicity [7]. GO was only discovered in 2004 and
since its discovery, few studies have reported on its effects on the immune system [2]. Graphene
oxide induced oxidative stress and immunotoxicity in vivo in zebrafish [1]. Upon in vitroexposure to
GONPs, decrease in cell viability, DNA damage, increased reactive oxygen species (ROS) production
and induction of inflammatory factors were recorded [4,8,9]. The cytokines selected in this in vitro
study (i.e., IL-6, IL-10 and IFNγ) are indicative of the inflammatory, humoral and cell mediated
immune systems respectively. They each play different but inter-connective roles. IL-6 has the ability
to stimulate T cell proliferation and their differentiation into cytotoxic T cells, stimulating antibody
production and the induction of acute phase proteins [10,11]. Whereas, IL-10 has the unique ability
to inhibit the expression and production of many lipopolysaccharide (LPS)-inducible genes, mainly
pro-inflammatory cytokines, by macrophages [12,13]. And IFNγ is produced mainly by activated
CD4+ or CD8+ T cells and natural killer (NK) cells and is recognized as the principal mediator of innate
and adaptive immunity [14,15]. Therefore, validating their selection as GONPs could potentially result
in immunotoxicity. Studies also showed that GONPs exhibited antibacterial effects against both gram
negative and gram positive bacteria [16].
The aim of current study was to investigate the in vitro effects of GONPs on the immune system
by exposing the murine macrophage cell line, RAW 264.7 and human whole blood cell cultures to
GONPs. A number of immune system biomarkers were monitored such as cytotoxicity, inflammatory
biomarkers, cytokines of the acquired immune system and a proteome profile analysis of cytokines
and chemokines expressed upon GONPs exposure.
2. Results
2.1. The Effects of GONPs on RAW 264.7 Cells
2.1.1. The Effects of GONPs on Viability of RAW 264.7 Cells
GONPs at concentrations ≤ 31.25 µg/mL did not have an effect on cell viability (Figure 1a).
However, GONPs concentrations ≥ 62.5 µg/mL significantly (p < 0.001) reduced cell viability. At the
highest concentration of GONP screened (500 µg/mL), the viability of cells was less than 60% of the
control cell viability (cells that did not receive GONP).
2.1.2. The Effects of GONPs on the Inflammatory System Biomarker Nitric Oxide (NO) Using RAW
264.7 Cells
GONPs had no effect on the inflammatory response from the cells in an unstimulated environment
across all the concentrations monitored in this study (Figure 1b). A LPS stimulated control without
any nanoparticle is included in the results to verify that the data obtained is not due to any artefacts
that were generated due to the exposure of GONPs to cells.
2.1.3. The Effects of GONPs on the Inflammatory System Biomarker IL-6 Using RAW 264.7 Cells
GONPs under unstimulated conditions induced a significant (p < 0.001) upregulation of IL-6
at 15.6 and 31.25 µg/mL respectively, when compared to the control culture that was not exposed
to GONP (Figure 1c). Conversely, IL-6 synthesis was not affected when cultures were exposed to
GONP concentrations ≥ 62.5 µg/mL. The results representing LPS stimulated cultures without any
nanoparticle exposure were not included in the graph due to the large scale of the data.
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Figure 1.Murine macrophage, RAW 264.7 cells after treatment with GONPs. Parameters assessed (a) 
cell viability; (b) nitric oxide production; (c) Interleukin 6 (IL-6) production; (d) Macrophage 
inflammatory protein 1 alpha (MIP-1α) levels. Positive control not represented (803.85 ± 353.70 
ng/mL MIP-1α); (e) MIP-1β levels. Positive control not represented (1127.19 ± 468.69 ng/mL MIP-1β); 
and (f) MIP-2 levels. Positive control not represented (307.39 ± 171.86 ng/mL MIP-2). Data represents 
mean ± SD with n = 9. Bars marked with symbols indicate significant difference to control (p < 0.01). 
Significance demarcated by: *—significantly different compared to negative control (p < 0.001), 
#—significantly different compared to positive control (p ≤ 0.005). 
2.1.4. The Effects of GONPs on the MIPs Chemokines Using RAW 264.7 Cells 
The Effects of GONPs on MIP-1α Using RAW 264.7 Cells 
GONPs in the range of 15.6–62.5 μg/mL in media only notably (p < 0.001) increased the 
synthesis of MIP-1α, compared to the culture control not exposed to GONP (Figure 1d). However, 
GONPs concentrations ≥ 125 μg/mL significantly decreased the synthesis of MIP-1α compared to the 
culture control which was not exposed to GONP. The results for control cultures exposed to media 
in the presence of a mitogen only (803.85 ± 353.70 ng/mL MIP-1α) are not included on the figure. 
The Effects of GONPs on MIP-1β Using RAW 264.7 Cells 
Cultures exposed to GONP concentrations in the range of 15.6–31.25 significantly (p < 0.001) 
upregulated the amount of MIP-1β secreted by the RAW cells compared to the culture control not 
exposed to GONP (Figure 1e). GONP concentrations ≥ 62.5 μg/mL, on the other hand significantly 
Figure 1. Murine macrophage, RAW 264.7 cells after treatment with GONPs. Parameters assessed (a) cell
viability; (b) nitric oxide production; (c) Interleukin 6 (IL-6) production; (d) Macrophage inflammatory
protein 1 alpha (MIP-1α) levels. Positive control not represented (803.85 ± 353.70 ng/mL MIP-1α); (e)
MIP-1β levels. Positive control not represented (1127.19 ± 468.69 ng/mL MIP-1β); and (f) MIP-2 levels.
Positive control not represented (307.39 ± 171.86 ng/mL MIP-2). Data represents mean ± SD with n = 9.
Bars marked with symbols indicate significant difference to control (p < 0.01). Significance demarcated
by: *—significantly different compared to negative control (p < 0.001), #—significantly different compared
to positive control (p ≤ 0.005).
2.1.4. The Effects of GONPs on the MIPs Chemokines Using RAW 264.7 Cells
The Effects of G Ps on IP-1α sing R 264.7 Cells
G Ps in the range of 15.6–62.5 µg/mL in media only notably (p < 0.001) increased the synthesis
of MIP-1α, compared to the culture control not exposed to GONP (Figure 1d). However, GONPs
concentrations ≥ 125 µg/mL significantly decreased the synthesis of MIP-1α compared to the culture
control which as not exposed to GONP. The results for control cultures exposed to media in the
presence of a mitogen only (803.85 ± 353.70 ng/mL MIP-1α) are not included on the figure.
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The Effects of GONPs on MIP-1β Using RAW 264.7 Cells
Cultures exposed to GONP concentrations in the range of 15.6–31.25 significantly (p < 0.001)
upregulated the amount of MIP-1β secreted by the RAW cells compared to the culture control not
exposed to GONP (Figure 1e). GONP concentrations ≥ 62.5 µg/mL, on the other hand significantly
reduced MIP-1β synthesis compared to the culture control containing no nanoparticle. Results of
media only exposed to LPS in the absence of GONP (1127.19± 468.69 ng/mL MIP-1β) are not included
in the figure.
The Effects of GONPs on MIP-2 Using RAW 264.7 Cells
GONP concentrations ≤ 62.5 µg/mL significantly (p < 0.001) increased MIP-2 synthesis compared
to the control cultures exposed to media only without any nanoparticle (Figure 1f). MIP-2 synthesis
was not affected by GONP concentrations ≥ 125 µg/mL. Media in the presence of LPS without GONP
(307.39 ± 171.86 ng/mL MIP-2) is not included on the figure.
2.1.5. Secretory Cytokine and Chemokine Profile of RAW 264.7 Cells UponGONP Treatment
Membranes exposed to media only, media in the presence of a mitogen and 15.6 µg/mL GONPs
allowed for the analysis of various cytokines and chemokines expressed by the cells upon the relative
exposure (Figure 2). Quantification of the membranes showed that the simulated inflammatory
response (media in the presence of LPS) allowed the cells to secrete certain cytokines and chemokines
that were not synthesized by the cells when exposed to media only and 15.6 µg/mL GONPs. These
proteins include: IFNγ-inducible protein 10 (IP-10); Granulocyte-macrophage colony-stimulating factor
(GM-CSF); IL-6; macrophage colony-stimulating factor (M-CSF); interleukin 27 (IL-27); interleukin 1
receptor antagonist (IL-1ra); and IL-β.
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Figure 2. The effect of graphene oxide nanoparticles (GONPs) on RAW 264.7 cells. Cells were 
incubated with (a) media only (negative control); (b) media in the presence of LPS and (c) 15.6 μg/mL 
GONPs in the absence of a mitogen. Supernatants were probed using the proteome profiler array as 
described in methods. Cytokines/chemokines that were detected were allocated numbers: 1, 3 and 16 
are reference spots; 2-IP-10; 4-G-CSF; 5-TNF-α; 6-GM-CSF; 7-IL-6; 8-JE; 9-sICAM-1; 10-MIP-1α; 
11-MIP-1β; 12-IL-1β; 13-MIP-2; 14-IL-1ra; 15-RANTES; 17-IL-27; 18-SDF-1. 
Figure 2. The effect of graphene oxide nanoparticles (GONPs) on RAW 264.7 cells. Cells were incubated
with (a) media only (negative control); (b) media in the presence of LPS and (c) 15.6 µg/mL GONPs in
the absence of a mitogen. Supernatants were probed using the proteome profiler array as described in
methods. Cytokines/chemokines that were detected were allocated numbers: 1, 3 and 16 are reference
spots; 2-IP-10; 4-G-CSF; 5-TNF-α; 6-GM-CSF; 7-IL-6; 8-JE; 9-sICAM-1; 10-MIP-1α; 11-MIP-1β; 12-IL-1β;
13- IP-2; 14-IL-1ra; 15-RANTES; 17-IL-27; 18-SDF-1.
However, the exposure of RAW cells to 15.6 µg/mL GONP in the absence of a mitogen affected
the synthesis of certain proteins that significantly differed (p < 0.001) from both the negative (media
only) and positive (media in the presence of LPS) controls. These cytokines and chemokines
include: Granulocyte-colony stimulating factor (G-CSF); tumor necrosis factor α (TNF-α); monocyte
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chemoattractant protein 1 (MCP-1)/JE; intracellular adhesion molecule 1 (ICAM-1); MIP-1α; MIP-2;
regulated on activation, normal T cell expressed and secreted (RANTES); and stromal cell-derived
factor 1 (SDF-1) (Figure 3).Nanomaterials 2018, 8, x FOR PEER REVIEW  5 of 16 
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2.2.2. The Effects of GONPs on the Inflammatory System Biomarker IL-6 Using Whole Blood Cell 
Cultures 
Cultures exposed to GONPs alone significantly (p < 0.001) increased the IL-6 release from the 
cells at all the concentrations monitored when compared to the culture control exposed to media 
only (Figure 5a). Conversely, GONPs concentrations in the presence of LPS significantly (p < 0.002) 
Figure 3. Quantification of cytokines secreted by RA 264.7 cultures not sti ulated with LPS after
treatment with medium only or medium containing 15.6 µg/mL GONPs. Membranes subjected
to chromogenic exposure. Data is represented as mean ± SD. Bars marked with symbols indicate
significant differences (p < 0.01). Significance demarcated by: *—significantly different compared to the
negative control (p < 0.001), #—significantly different compared to the positive control (p < 0.001).
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2.2.1. The Effects of GONPs on Viability of Whole Blood Cell Cultures
GONP concentrations ≤ 50 µg/mL had no effect on cell viability (Figure 4). However, the highest
concentration of GONP evaluated, 500 µg/mL, significantly (p < 0.003) reduced viability compared to
cultures exposed to media only in the absence of GONP.
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2.2.2. The Effects of GONPs on the Inflammatory System Biomarker IL-6 Using Whole Blood
Cell Cultures
Cultures exposed to GONPs alone significantly (p < 0.001) increased the IL-6 release from the
cells at all the concentrations monitored when compared to the culture control exposed to media only
(Figure 5a). Conversely, GONPs concentrations in the presence of LPS significantly (p < 0.002) reduced
the secretion of IL-6 from the cells in a dose dependent manner compared to the control, exposed to
media only containing the mitogen.
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differences (p < 0.01). Significance demarcated by: *—significantly different compared to negative
control (p < 0.001), #—significantly different compared to positive control (p < 0.001).
2.2.3. The Effects of GONPs on the Inflammatory Chemokine, MIP-1β Using Whole Blood
Cell Cultures
IP-1β as significantly (p < 0.001) upregulated by GONPs under unstimulated conditions at 5
and 50 µg/mL respectively, when compared to the culture control, not containing any nanoparticle
(Figure 5b). o ever, under a si ulated infla atory response, Ps exhibited a pro inent
(p < 0.001) reduction in IP-1β synthesis at concentrations ≥ 50 µg/ L hen co pared to the culture
control, edia only containing LPS.
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concentrations 50 µg mL in the absence of significantly (p 0.002)
upregulatednIL-10 production compared to the culture control, not containing nanoparticle (Figure 6a).
However, the highest concentration (500 µg/mL) of the unstimulated cultures had no effect on the
adaptive immune response. On the other hand, GONPs concentrations in the presence of
significantly (p < 0.001) inhibited IL-10 secretion in a dose ependent manner compared to the culture
control, which only contained PHA.
2.2.5. The Effects of GONPs on the Cell Mediated Immune System Biomarker, IFNγ Using Whole
Blood Cell Cultures
GONP concentrations did not affect the cell mediated cytokine, IFNγ under normal conditions
(i.e., in the absence of PHA) (Figure 6b). However, GONPs notably (p < 0.001) reduced the synthesis of
IFNγ in a dose dependent manner in PHA stimulated cultures compared to media only containing
PHA (culture control). This dose dependent decrease of IFNγ mimicked the response of the other
adaptive immune cytokine, IL-10 (Figure 6a).
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exposed to GONPs in the absence or presence of PHA: (a) IL-10 expression levels and (b) IFNγ
expression levels. Data represents mean ± SD with n = 4. Bars marked with symbols indicate
significant differences (p < 0.01). Significance demarcated by: *—significantly different compared to
negative control (p < 0.001), #—significantly different compared to positive control (p < 0.001).
2.2.6. Secretory Cytokine and Chemokine Profile of Whole Blood Cell Cultures Upon
GONP Treatment
The proteome profile of whole blood cell cultures exposed to media only (negative control), media
containing the mitogen, LPS (positive control) and 5 µg/mL GONPs in the absence of a stimulus
revealed notable changes in the synthesis or inhibition of a number of cytokines and chemokines
(Figure 7).
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media and LPS, (c) 5 μg/mL GONPs in the absence of LPS. Cytokines/chemokines that were detected 
were allocated numbers: 1, 2 and 13 are reference spots; 3-IL-1ra; 4-MIF; 5-MCP-1; 6-Serpin E1; 
7-MIP-1α/β; 8-RANTES; 9-ICAM-1, 10-IL-6, 11-IL-8 and 12-IL-1β. 
Figure 7. The effects of GONPs on whole blood cells. Cells were incubated with (a) media only,
(b) media and LPS, (c) 5 µg/mL GONPs in the absence of LPS. Cytokines/chemokines that were
detected were allocated numbers: 1, 2 and 13 are reference spots; 3-IL-1ra; 4-MIF; 5-MCP-1; 6-Serpin
E1; 7-MIP-1α/β; 8-RANTES; 9-ICAM-1, 10-IL-6, 11-IL-8 and 12-IL-1β.
Figure 8 represents the quantification of the membranes. The whole blood cell cultures exposed to
GONPs caused the significant upregulation of macrophage migration inhibitory factor (MIF), MCP-1
and interleukin 8 (IL-8) compared to both controls. The GONPs also notably upregulated serpin
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E1, RANTES and ICAM-1 compared to the negative control. Cytokines and chemokines that were
prominently down regulated compared to the positive control include IL-1ra, MIP-1α/β, IL-6 and
IL-1β (Figure 8). Whole blood cells exposed to media only (negative control) did not synthesize the
following cytokines: IL-1ra, MCP-1, MIP-1α/β, IL-6, IL-8 and IL-1β.Nanomaterials 2018, 8, x FOR PEER REVIEW  8 of 16 
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3. iscussion
raphene has attracted lots of attention due its nu erous potential industrial and edical
applications. o ever, very little is kno n about the effects of these nanoparticles on the i une
syste . The exposure of cells to Ps induced cytotoxicity at the highest concentration
(500 µg/ L). Si ilar data as obtained by Li et al. ho exposed pristine graphene to 264.7
cells [17]. They proposed that Ps exerted its cytotoxic effects by depleting the itochondrial
e brane potential and increased the production of ROS. The decrease in cell viability could also
be attributed to the higher capacity of macrophages to internalize GO and this could have affected
the assembly of actin within the cell [18,19]. A reduction in cell viability was also reported hen
exposing hu an T P-1 cells to Ps, indicating consistent cytotoxic effects against acrophages
and onocytes regardless of species [4].
In the current study, infla atory and proteo e profiling data for Ps, at basal conditions,
increased the synthesis of infla atory cytokines and che okines such as , IL-6, T F-α, IPs
and R TES. These findings ere corroborated by recchioni et al. as it as reported that, Ps
significantly sti ulated the secretion of Th1/Th2 cytokines, such as IL-1a, IL-6, IL-10, T F-α and
- SF, as ell as che okines such as P-1, IP-1α, IP-1β and R TES in pri ary and
i ortalized urine acrophages [20]. This indicates activation of the acrophages by Ps
and could potentially be attributed to the interaction of Ps ith the toll-like receptors [21,22].
Feito et al. found that RAW 264.7 cells exposed to poly(ethylene glycol-amine) (PEG) functionalized GO
upregulated TNF-α under both basal and LPS stimulated conditions [18]. IL-6 was found to be down
regulated at 25 and 100 µg/mL GO in a simulated infla matory response (+LPS). No differences were
seen in IL-6 levels under basal conditions. The TNF-α result obtained by Feito et al. is consistent with
what was found in the current study using proteome profiling [18]. The infla matory cytokine, IL-6
was significantly upregulated at 15.6 and 31.25 µg/mL in the absence of a mitogen in the current study.
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This is contradictory to what was found by Feito et al but could be attributed to the functionalization
of GO [18]. Functionalization of nanoparticles with biocompatible polymers increases their stability
under physiological conditions. It also minimizes their interactions with other biomolecules and
reduce immunological responses [8,18]. The effects of GONPs on RAW cells, under LPS stimulated
conditions, were not evaluated in the current study.
Similarly to the RAW cells, GONPs also induced cytotoxicity in whole blood cell cultures at
500 µg/mL, and Orecchioni et al. exposed GONPs to peripheral blood mononuclear cells (PBMCs)
and found that it induced its cytotoxic effects by inducing ROS-mediated apoptosis [6,23]. Zhi et al.
also found that GO induced apoptosis in T lymphocytes in a dose dependent manner [24].
Exposing whole blood cell cultures to GONPs also induced the upregulation of the inflammatory
cytokines IL-6 and MIP-1β under unstimulated/basal conditions. This activation of the inflammatory
response could be attributed to the activation of the complement system which results in the production
of anaphylatoxins (proinflammatory mediators). This may occur as GO may be sensed by components
of the complement system as soon as GO is introduced into a biological system [25]. The activation of
the complement system was studied by Wibroe et al. who found that there was an increase in C5a,
which is a marker of the activation of the complement system when exposing human serum to GO [26].
Wibroe et al. also found that GO reduced the synthesis of IL-6 when human serum was stimulated by
LPS, which is consistent with what was found in this study [26]. Proteome profiling data obtained in
the current study confirmed that inflammatory cytokines and chemokines were activated when whole
blood cell cultures were exposed to 5 µg/mL GONPs. Notably, IL-1ra, MCP-1, MIP-1α/β and IL-8
were upregulated by the GONPs.
GONPs not only inhibited an inflammatory response in a dose dependent manner but also
modulated cytokines regulating the adaptive immune responses. The GONPs stimulated the synthesis
of the humoral immune regulating cytokine, IL-10 but did not affect the cell mediated response
regulating cytokine, IFNγ, from whole blood cell cultures under unstimulated/basal conditions. This
indicates that GONPs would induce the differentiation of Th0 cell to Th2 cells. The B-lymphocytes are
then stimulated to produce antibodies by interleukin 4 and 10 (IL-4 and IL-10) to combat the exposure
to GONPs [27]. However, both IL-10 and IFNγ responses by whole blood cell cultures under PHA
stimulated conditions were down regulated by GONPs.
This study clearly indicates that GONPs are cytotoxic at high concentrations and stimulates the
activation of inflammatory responses under unstimulated/basal conditions. This activation/stimulation
of an inflammatory response could cause autoimmunity to individuals exposed to GONPs [28].
Under unstimulated/basal conditions GONPs would also stimulate a humoral immune response in
individuals exposed to them. However, under stimulated conditions mimicking an infection, both
humoral and cell mediated responses were down regulated, indicating potential immunosuppression
by GONPs exposure to individuals with an infection.
The data obtained in the current study is crucial for risk management of people upon GONP
exposure, as these nanoparticles could be used in vivo as drug delivery systems, among other
applications. GONPs may also be released into the environment and can potentially impact on
human health.
4. Materials and Methods
4.1. Synthesis and Characterization of Graphene Oxide Nanoparticles (GONPs)
The graphene oxide nanoparticles were synthesized according to a modified Hummers’ method [29],
characterized and obtained from the University of Missouri. Graphene sheets were visualized via
transmission electron microscopy (TEM, JEOL 1400, Peabody, MA, USA). Further characterization
revealed the particles had a maximum absorbance at 227 nm with ultraviolet-visible spectrophotometry
(UV-vis) (Lab Tech, UV 8100B, Hopkinton, MA, USA), with a scanning range 200–600 nm.
A number of surface functional groups (i.e., hydroxyl and carboxyl groups) were detected by
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Fourier-transform infrared spectroscopy (FT-IR) in a Nicolet 4700 FT-IR spectrophotometer (Thermo
scientific, Waltham, MA, USA) and the spectra collected over a wave number range from 400 to
4000 cm−1. The electrophoretic mobility (EPM) of the nanomaterials was measured with a ZetaSizer
Nano ZS (Malvern Instruments, Worcestershire, UK) in various electrolyte solutions by laser
Doppler velocimetry. EPMs were converted to zeta-potential using the Smoluchowski equation
(Equation (1)) [30]:
U = εζ/µ, (1)
where U is the electrophoretic mobility, ε is the dielectric constant of the solution, µ is its viscosity and
ζ is the zeta potential. Disposable folded capillary cells were employed. Zeta potential indicated a
surface potential of−49.2 mV at pH 7 and background ionic strength of 10 mM, NaCl (see Appendix A).
4.2. Preparation of GONPs
A 10 mg/mL stock of GONPs in distilled water was prepared. The GONPs were sonicated
(QSonica, LLC. Misonixsonicators, XL-200 Series, Newtown, CT, USA) in short busts, one ice for a total
of approximately 90 min. Aliquots of the stock solution were frozen at −80 ◦C until use. Before use in
experiments, nanoparticles were thawed and further sonicated in short bursts on ice for 5 min.
4.3. RAW 264.7 Cells
4.3.1. RAW 264.7 Macrophage Assay
The murine macrophage cell line, RAW 264.7, was obtained from American Type Culture
Collection (ATCC TIB-71, Manassas, VA, USA). The RAW 264.7 cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM, Lonza, Cape Town, South Africa) supplemented with 10% heat
inactivated fetal bovine serum (FBS, Hyclone, Little Chalfont, UK), glutamax (Sigma-aldrich, St. Louis,
MO, USA), antibiotic/antimycotic (Sigma-aldrich) and gentamicin (Sigma-aldrich). The cells were
incubated in a humidified atmosphere of 5% CO2 at 37 ◦C and the cells were sub-cultured every
2–3 days.
The RAW 264.7 cells (1 × 105 cells/mL) were cultured in cell culture treated 48 well plates
and incubated in a humidified atmosphere of 5% CO2 at 37 ◦C for approximately 48 h until the
cells reached 80–90% confluence. After the incubation period, media was removed and replace with
media containing 2.5% FBS. The subsequent procedures occurred in serum free media. The cells
were pre-exposed for 2 h to various concentrations of GONPs. Thereafter the cells were left
unstimulated and a positive control was also present. The positive control were cells only stimulated
by lipopolysaccharide (LPS) (1 µg/mL) without the presence of nanoparticles and this would mimic
an inflammatory immune response. The final concentration of FBS/well was 0.5%. Cultures were
incubated overnight (~18 h) under standard tissue culture conditions. Culture supernatants were
collected for nitric oxide (NO), interleukin 6 (IL-6), macrophage inflammatory protein 1α (MIP-1α),
MIP-1β, MIP-2 and proteome profiling analysis.
4.3.2. Cytotoxicity Assay
After the removal of the supernatants, cells were washed with Dulbecco’s Phosphate Buffered Saline
(DPBS) (Lonza), supplemented with glutamax, antibiotic/antimycotic solution. Cytotoxicity was measured by
adding 150 µL of a 1/10 dilution of 2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium
(WST-1, Roche, Basel, Switzerland) reagent in serum free medium to each well. Metabolically active
cells convert WST-1 reagent to a formazan that can be measured spectrophotometrically. Formazan
formation was determined by reading the plate at 450 nm (Multiskan Ex, Thermo Electron Corporation,
Waltham, MA, USA) immediately after WST-1 addition and again after an incubation period of 1 h
at 37 ◦C. The increase in absorbance at 450 nm is proportional to formazan formation. The level of
fomazan formed is directly proportional to cell viability.
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4.3.3. NO Determination
After the overnight incubation of the RAW 264.7 cells, the amount of nitrite that was produced
by the cells was measured in the culture supernatant as an indication of NO production. The NO
assay is based on the Griess reaction [31]. The amount of NO production was measured against a
doubling dilution range of a 100 µM nitrite standard (Sigma-aldrich). Nitrite standards or culture
supernatant collected (100 µL) were mixed with 100 µL of Griess reagent (1:1 of 1% sulfanilamide
and 0.1% naphtylethlemidimine-dihydrochloride in 2.5% phosphoric acid) (all reagents obtained from
Sigma-aldrich). Thereafter, the plate was incubated at room temperature for 15 min. The absorbance
was read at 540 nm by a microplate reader (Multiskan Ex, Thermo Electron Corporation) and the
amount of NO produced by the RAW cells quantified.
4.3.4. Mouse IL-6 Double Antibody Sandwich (DAS) Enzyme Linked Immunosorbent Assay (ELISA)
The mouse IL-6 ELISA (e-Bioscience, Ready-Set-Go, Waltham, MA, USA) kits were used to
measure IL-6 cytokine levels in the cell culture supernatants. The LPS stimulated control was assayed
at (1/40) while the negative control (not treated with LPS) was assayed at (1/5) in assay diluent.
Assays were performed in 96 well Nunc maxisorb plates. The kit contained all the reagents for the
assay and was performed as per the manufacturer’s instructions (see addendum).
4.3.5. Mouse MIPs (MIP-1α, MIP-1β and MIP-2) DAS ELISAs
Mouse MIP-1α, MIP-1β and MIP-2 ELISAs (R & D Systems, Minneapolis, MN, USA) were
performed on the samples and the LPS stimulated culture supernatants. The kits contained all the
reagents required for the experiment and experiments were performed as per the manufacturer’s
instructions. The samples were all diluted in reagent diluent, 1% human serum albumin (HSA) (w/v).
The MIP-1α samples were assayed at 1/270 and the LPS stimulated supernatant at 1/10,000. For the
MIP-1β ELISA, the unstimulated culture supernatants were assayed at 1/20 while the LPS stimulated
supernatants were assayed at 1/5000. The MIP-2 ELISA unstimulated supernatants were assayed at
1/100 and the mitogen stimulated supernatant at 1/1000.
4.3.6. Mouse Proteome Profiling Assay
A commercially available antibody array kit (Proteome Profiler, Mouse cytokine Array Panel
A, R & D Systems) which was coated with 40 capturing antibodies in duplicate on a nitrocellulose
membrane (dot blot) was used. The kit contained all the reagents for the assay and was performed
as per the manufacturer’s instructions. This cytokine and chemokine antibody array was used to
determine the effects of GONPs exposure on cytokine and chemokine by RAW 264.7 macrophage
cells.The assay required 500 µL of cell culture supernatants (unstimulated 0 µg/mL GONPs, LPS
stimulated 0 µg/mL GONPs and unstimulated 15.6 µg/mL GONPs). Membranes were subjected to
an ultra-sensitive chromogenic 3,3′,5,5′-Tetramethylbenzidine (TMB) membrane substrate (Thermo
Scientific, Waltham, MA, USA) to reveal sample-antibody complexes labeled with streptavidin-HRP.
Photographs were taken of the blots after the exposure to the substrate.
4.3.7. Quantification of Pixel Density for Cytokine and Chemokine Membranes
Membrane images were quantified using image processing and analysis Java software(version
1.6.0_24, Oracle Corporation, Redwood city, CA, USA), ImageJ (version 1.4.3.67, National Institutes of
Health, Bethesda, MD, USA). Levels of cytokines and chemokines were expressed as a percentage of
the reference spot. Microsoft Excel was used to calculate the percentages which is expressed as mean ±
standard deviation (SD).
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4.4. Whole Blood Cell Culture
4.4.1. Blood Collection
Blood was collected by a doctor/nurse from a healthy male who was not using any medication.
The blood was collected using venipuncture directly into 3.2% sodium citrate vacuum tubes (Greiner
bio-one). The blood was processed immediately. The whole blood cell cultures were performed under
sterile conditions. Ethical clearance was obtained from the University of the Western Cape (Ethics No.
10/9/43). Informed consent was also obtained from the participant.
4.4.2. Cell Culture
Human whole blood was diluted with Roswell Parks Memorial Institute (RPMI) 1640 media
(Sigma-aldrich) to give rise to a 10% (v/v) mixture. Blood was either left unstimulated or stimulated
with LPS (Sigma-aldrich) (0.1 µg/mL) or phytohaemmagglutinin (PHA) (Sigma-aldrich) (1.6 µg/mL).
The stimulated conditions would mimic an inflammatory and acquired immune response respectively.
Unstimulated or stimulated whole blood cell cultures were incubated overnight at 37 ◦C with high,
intermediate and low concentrations of GONPs in a 24 well tissue culture treated plate (Nunc, Waltham,
MA, USA). Along with the nanoparticle exposure, a positive control of 0.01% Tween20 (Merck,
Modderfontein, South Africa) was also present. After the incubation period, culture supernatants were
screened for cytotoxicity by a lactate dehydrogenase (LDH) assay, inflammatory markers IL-6 and
MIP-1β, interleukin 10 (IL-10) and interferon gamma (IFNγ).
4.4.3. LDH Assay
After the overnight incubation, an aliquot of the unstimulated whole blood cell culture
supernatants were screened for cytotoxicity and measured the release of LDH from the cells
(LDH-cytotoxicity colorimetric kit II, BioVision, Milpitas, CA, USA). The kit contained all the reagents
for the assay and was performed as per the manufacturer’s instructions.
4.4.4. Cytokine Analysis Using DAS ELISAs
Commercially available kits (e-Bioscience, Ready-Set-Go) were used to analyze the level of
cytokine secretion from the whole blood cell cultures. The kits were used as per the manufacturer’s
instructions and contained all the reagents to complete the assay. The unstimulated and LPS stimulated
samples were analyzed using a 1/10 dilution for the IL-6 assay. While the unstimulated and PHA
stimulated samples were assayed neat for IL-10 and IFNγ analysis. The same protocol was used as
previously described for the mouse cytokine ELISA.
4.4.5. Human MIP-1β DAS ELISAs
A human MIP-1β ELISA (R & D Systems) was performed on the unstimulated and LPS stimulated
culture supernatants of the whole blood cell cultures. The samples were diluted 1/10 in reagent diluent,
0.1% bovine serum albumin (BSA) (Sigma-aldrich). The same protocol was followed as the mouse
MIPs ELISAs.
4.4.6. Human Proteome Profiling
A commercially available antibody array kit (Proteome Profiler, Human Cytokine Array Kit, R &
D Systems) which was coated with 36 capturing antibodies in duplicate on a nitrocellulose membrane
(dot blot) was used. The kit contained all the reagents for the assay and was performed as per the
manufacturer’s instructions. This cytokine and chemokine antibody array was used to determine the
effects of GONPs on cytokine and chemokine secretion when exposed to whole blood cell cultures.
The assay required 500 µL of cell culture supernatants (unstimulated 0 µg/mL GONPs, LPS stimulated
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0 µg/mL GONPs and unstimulated 5 µg/mL GONPs). The subsequent steps were carried out as
described for the mouse cytokine and chemokine proteome profiling.
4.5. Statistical Analysis
All experiments were performed in triplicate and the data was calculated using Microsoft Excel.
Data is presented as mean ± standard deviation (SD). One way analysis of variance (ANOVA) using
SigmaPlot 12.0 (Systat Software Inc., San Jose, CA, USA) was used to assess statistical differences with
p < 0.01 being deemed significant.
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Appendix
The FTIR spectra of GO is presented in Figure A1. Different types of oxygen functionalities were
confirmed in the GO spectrum: at 3300 cm−1 (O–H stretching vibration), at 1740 cm−1 (stretching
vibration from C=O), at 1619 cm−1 (C=C stretch), at 1360 cm−1 (C–O stretch), at 1201 cm−1 (C–OH
stretching vibration) and finally at 1060 cm−1 (C–O stretching vibration). The UV-vis adsorption
spectra of the GO sheets showed a characteristic peak at 227 nm (Figure A2) due to the pi→pi* transition
of the C=C bonds. Figure A3 shows a representative TEM image of a GO particle, settled from a
suspension at pH = 5.2 and absence of added electrolytes, evidencing its two-dimensional morphology.
The dimensions of the sheets observed were about 1–2 µm, although some smaller particles probably
from partial breaking of the initial GO sheets were detected. However, in the presence of 10 mM NaCl,
the size of the GO sheets decreased from 1555 ± 248.57 nm to 519.97 ± 36.59 nm as a pH increased
from 2 to 11 (Table A1). Figure A4 shows that the ζ-potential of GO particles was negative over the
pH range from 2 to 11. In the presence of 10 mM NaCl, ζ-potential values decreased from −23.24 ±
0.72 to −51.1 ± 1.04 mV as a pH increased from 2 to 11 due to the deprotonation of oxygen functional
groups [32]. The ζ-potential vs. pH curve displayed two inflection points, located at around pH 4 and
pH 9. FTIR spectra (Figure A1) showed that GO has two types of acidic groups: carboxylic (pKa, 4.3)
and hydroxylic (pKa, 9.3); increased negative charges on GO sheets resulted from the ionization of
these two groups [33].
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